ISRCTN37591328
Active, Not Recruiting
N/A
Risk-adapted prostate cancer (PCa) early detection study based on a baseline” PSA value in young men – a prospective multicenter randomized trial (PROBASE)
German Cancer Aid0 sites46,000 target enrollmentJanuary 15, 2020
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- German Cancer Aid
- Enrollment
- 46000
- Status
- Active, Not Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
2023 Interim results article in https://doi.org/10.1016/j.eururo.2023.09.027 (added 23/10/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Males at age 45 at the time of consent
- •2\. Willing and able to provide written informed consent
- •3\. Written data protection consent has been obtained
- •4\. Able to adhere to the study visit schedule and requirements of the protocol
Exclusion Criteria
- •Previous history of prostate cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Active surveillance for early prostate cancer: international study (PRIAS-JAPAN)JPRN-UMIN000002874Kagawa university1,400
Completed
N/A
Prostate Cancer Antigen 3 (PCA-3) Gene ProjectProstate CancerBenign Prostatic HypertrophyNCT01177436Assistance Publique Hopitaux De Marseille31
Active, Not Recruiting
N/A
The ProCaRis Study: Prostate Cancer Risk Assessment in General PracticeProstate CancerNCT01739062University of Aarhus5,000
Unknown
N/A
Early and Accurate Detection of Prostate Cancer in General PracticeProstate CancerProstate NeoplasmProstate AdenocarcinomaNCT03431753Aarhus University Hospital3,000
Unknown
N/A
Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPVProstate CancerPSANCT04251546Xinhua Hospital, Shanghai Jiao Tong University School of Medicine80